Abstract:Background: Ginsenosides were considered as the main bioactive constituents in Ginseng Radix et Rhizoma (GRR). However, because of high polarity, ginsenosides were hard to be absorbed in human or animal gastrointestinal tract after oral administration. Up to now, very few studies have been performed in the area of simultaneous pharmacokinetic analysis of multiple ginsenosides with similar structures. Purpose: This research aimed to compare the different absorption characteristics of ginsenosides and aglycones between GRR and Baoyuan decoction (BYD), one of formulas containing GRR, with the same dosage. Methods: GRR and BYD extracts were prepared with same method. A single dose of GRR and BYD extracts were administrated to rats through gavage, respectively. A solid phase extraction method was used to purify the plasma samples. An ultra-fast liquid chromatography coupled with tandem mass spectrometry (UFLC-MS/MS) method was established and fully validated for quantitative analysis. In addition, an in vitro incubation of GRR extract with intestinal flora was conducted to confirm the influence of gut microbiota to the absorption of ginsenosides and aglycones. Results: The results of incubation experiments showed that most high polar ginsenosides could transform to less polar ginsenosides via intestinal flora. The validated UFLC-MS/MS method was sensitive and precise to simultaneously analyze the pharmacokinetics of multiple ginsenosides. After oral administration of GRR and BYD extracts, the pharmacokinetic results showed that a total of 11 ginsenosides and 2 aglycones could be quantitatively determined in both groups of plasma. Besides, five compounds were only quantified in BYD extract group. In addition, another 21 ginsenosides could be qualitatively measured. Conclusion: The results indicated significant pharmacokinetic differences of ginsenosides and aglycones between two groups. For most less polar ginsenosides who had better bioactivity, the preparation was possessed of higher plasma concentrations. The comparative results indicated that some co-existing compounds in BYD might inhibit the exocytosis of ginsenosides. Moreover, what is worth mentioning, some ginsenosides and aglycones could only be detected and quantified a few hours later after administration to rats. Combining with the in vitro incubation experiments, the results demonstrated that transformation of ginsenosides in gastrointestinal tract via intestinal flora existed during absorption.

In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota

Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species

Metabolic Characteristics of Ginsenosides from Panax Ginseng in Rat Feces Mediated by Gut Microbiota.

Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities

Pharmacokinetics of Ginsenosides Rg1, Re and Notoginsenoside R1 in Rats by an in vivo Microdialysis Coupled with Liquid Chromatography/Mass Spectrometry

Quantification of Panax Notoginseng Saponins Metabolites in Rat Plasma with in Vivo Gut Microbiota-Mediated Biotransformation by HPLC-MS/MS

Biotransformation differences of ginsenoside compound K mediated by the gut microbiota from diabetic patients and healthy subjects

Identification and Quantitative Investigation of the Effects of Intestinal Microflora on the Metabolism and Pharmacokinetics of Notoginsenoside Fc Assayed by Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry

In Vivo Metabolic Profiles of Panax Notoginseng Saponins Mediated by Gut Microbiota in Rats

Impact of ginsenoside Rb1 on gut microbiome and associated changes in pharmacokinetics in rats

Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K

Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota

A narrative review of the pharmacology of ginsenoside compound K

Bioconversion variation of ginsenoside CK mediated by human gut microbiota from healthy volunteers and colorectal cancer patients

Effect of Lactic Acid Bacteria on the Pharmacokinetics and Metabolism of Ginsenosides in Mice

Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of<i>Panax ginseng</i>

Metabolic Analysis of Panax Notoginseng Saponins with Gut Microbiota-Mediated Biotransformation by HPLC-DAD-Q-TOF-MS/MS

Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of <scp> <i>Panax ginseng</i> </scp>

Comparative Analysis on Microbial and Rat Metabolism of Ginsenoside Rb-1 by High-Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry

Pharmacokinetics Comparison of 15 Ginsenosides and 3 Aglycones in Ginseng Radix Et Rhizoma and Baoyuan Decoction Using Ultra-Fast Liquid Chromatography Coupled with Triple Quadrupole Tandem Mass Spectrometry.

Pharmacokinetic Studies of Chemical Constituents of Ginseng